Lymphocyte to C-reactive protein ratio predicts long-term outcomes for patients with lower rectal cancer

Lymphocyte to C-reactive protein ratio predicts long-term outcomes for patients with lower rectal cancer

Abstract Backgrounds The lymphocyte to C-reactive protein (CRP) ratio (LCR) is an indicator of systemic inflammation and host–tumor cell interactions. The aim of this study was to investigate the prognostic significance of LCR in lower rectal cancer patients who received preoperative chemo-radiother...

Full description

Bibliographic Details
Main Authors: Masaaki Nishi, Mistuo Shimada, Takuya Tokunaga, Jun Higashijima, Kozo Yoshikawa, Hideya Kashihara, Chie Takasu, Daichi Ishikawa, Yuma Wada, Shohei Eto, Toshiaki Yoshimoto
Format: Article
Language:English
Published: BMC 2021-07-01
Series:World Journal of Surgical Oncology
Subjects:
Rectal cancer
Chemoradiotherapy
Lymphocyte-CRP ratio
Online Access:https://doi.org/10.1186/s12957-021-02319-x

Similar Items

Similar Items